Navigation Links
InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Date:9/2/2008

p>About the Roche/InterMune Collaboration

In October 2006, Roche and InterMune announced an exclusive worldwide collaboration to develop and commercialize products from InterMune's HCV protease inhibitor program, including ITMN-191. The companies also collaborate on a research program to identify, develop and commercialize novel second-generation HCV protease inhibitors.

At closing, InterMune received from Roche an upfront payment of $60 million, and in 2007 received a $10 million manufacturing milestone and a $10 million development milestone. In addition to the $15 million milestone being announced today, assuming the continued successful development and commercialization of ITMN-191 in the United States and other countries, InterMune could potentially receive up to an additional $435 million in milestones.

Roche funds 67% of the global development costs of ITMN-191. The companies will co-commercialize the product in the United States and share profits on a 50/50 basis. InterMune will receive royalties outside the United States.

Roche has rights to other HCV protease inhibitor development candidates resulting from the research collaboration. The economic terms for ITMN-191 also apply to additional compounds that InterMune and Roche may develop and commercialize.

In early April 2008, InterMune reported top-line results in the four dose cohorts of treatment-naive patients in a Phase 1b multiple-ascending-dose (MAD) monotherapy trial of ITMN-191 in patients chronically infected with HCV genotype 1. ITMN-191 demonstrated significant and rapid viral kinetic activity and excellent safety and tolerability in all dosage regimens. Also in early April, InterMune announced that 13-week preclinical studies in rats and monkeys were successfully completed which were necessary before initiation of clinical studies in Phase 2 with longer treatment durations than those performed to date with ITMN-191.

In late May 2008, InterMune initiated
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... State College, PA (PRWEB) August 27, 2014 ... Electromagnetic Simulation Software with new features for the ... release is an enhanced Biological Thermal Sensor, exclusive to ... is a specialty version of XFdtd, developed to calculate ... MATLAB® export functionality has been added to all versions ...
(Date:8/26/2014)... the thinnest-possible semiconductor, a new class of nanoscale ... , The University of Washington researchers have demonstrated ... be connected in an atomically seamless fashion known ... basis for next-generation flexible and transparent computing, better ... "Heterojunctions are fundamental elements of electronic and photonic ...
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
Breaking Biology Technology:BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2
... , vW Select Significantly Reduces Laboratory Variability and Provides ... HORSHAM, Pa., June 30 Today, Bio/Data Corporation announced ... Ristocetin CoFactor Assay. vW Select is the first and ... the von Willebrand Factor. A deficiency of von Willebrand ...
... , LOURES, Portugal, June 30 ... inspection by FDA. , The inspection, ... office in Buffalo and Mr. ChunChang Fang, Chemist from,California District ... 22nd June and concluded on the 24th. A Form 483 ...
... Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, ... 3000 Index following Russell Investments, reconstitution of its comprehensive set ... Insmed was also added to the Russell Microcap(R) Index. ... the 4,000 largest U.S. stocks as of the end of ...
Cached Biology Technology:Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay 2FDA Inspects Hovione's API Manufacturing Plant in Macau 2Insmed Announces Addition to the Russell 3000(R) Index 2
(Date:8/26/2014)... BOULDER -- Unregulated trash burning around the globe is ... by official records. A new study led by the ... 40 percent of the world,s garbage is burned in ... affect human health and climate change. , The new ... basis, of pollutants such as particulates, carbon monoxide, and ...
(Date:8/26/2014)... recommended investing in dog owner education and facilities as a ... in both people and their pets. , In a review ... access to dog-friendly walking environments and better education about dogs, ... take more exercise with their pets. , It is estimated ... a walk. In the UK, almost a quarter of households ...
(Date:8/25/2014)... the biofuels industry: "You can make anything from ... may pave the way to challenging that adage. ... Energy Laboratory (NREL) demonstrates a concept that provides ... a variety of renewable fuels, chemicals, and materials ... Valorization Through Integrated Biological Funneling and Chemical Catalysis ...
Breaking Biology News(10 mins):Trash burning worldwide significantly worsens air pollution 2Trash burning worldwide significantly worsens air pollution 3Education and dog-friendly neighbourhoods could tackle obesity 2New process helps overcome obstacles to produce renewable fuels and chemicals 2
... Prize for Environmental Achievement for his work in helping ... is awarded annually to individuals with world-class environmental accomplishments ... Professor of Environmental Biology, will share the prize, which ... with James Galloway, a professor of environmental sciences at ...
... J. and Frances F. Young Professor of Bacteriology in ... Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech, ... Department of Agriculture to study the role biofilm plays ... The $374,000 grant will allow Inzana and his ...
... of the most remote regions of the planet, Waleed Abdalati, ... Flight Center in Greenbelt, Md., has witnessed remarkable changes in ... satellites offer further visual evidence that all is not as ... Earth. On Thursday, April 10, Abdalati, who is one ...
Cached Biology News:Harold Mooney wins prestigious Tyler Prize for Environmental Achievement 2Veterinary college researchers explore function of biofilm in bovine respiratory disease 2NASA expert to address Earth's vanishing polar ice, April 10, at UD 2
... The H2OBIT™ is a fully licensed, high throughput, ... processing of up to 24 microplates. This equates ... plates. A robotic arm rapidly transfers ... resulting in temperature ramping times that are considerably ...
... ONE Ribonuclease is a 27kDa periplasmic enzyme ... of RNA to cyclic nucleotide monophosphate (NMP) ... of these intermediates to 3-NMPs (1). RNase ... known RNases that can cleave a phosophodiester ...
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
...
Biology Products: